Shares of Abiomed (NASDAQ: ABMD) soared 50% on Tuesday after the medical device maker struck an acquisition deal with Johnson & Johnson (NYSE: JNJ). 

J&J will make a tender offer for Abiomed's publicly traded shares. Under the terms of the agreement, Abiomed's share owners would receive $380 per share in cash, representing an enterprise value of roughly $16.6 billion.

Abiomed shareholders will also earn an additional $35 per share in cash if certain sales and development milestones are reached.

Continue reading

Source Fool.com